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Abstract: Hantaviruses, similar to
several emerging zoonotic viruses,
persistently infect their natural res-
ervoir hosts, without causing overt
signs of disease. Spillover to inci-
dental human hosts results in
morbidity and mortality mediated
by excessive proinflammatory and
cellular immune responses. The
mechanisms mediating the persis-
tence of hantaviruses and the
absence of clinical symptoms in
rodent reservoirs are only starting
to be uncovered. Recent studies
indicate that during hantavirus
infection, proinflammatory and an-
tiviral responses are reduced and
regulatory responses are elevated
at sites of increased virus replica-
tion in rodents. The recent discov-
ery of structural and non-structural
proteins that suppress type I inter-
feron responses in humans sug-
gests that immune responses in
rodent hosts could be mediated
directly by the virus. Alternatively,
several host factors, including sex
steroids, glucocorticoids, and ge-
netic factors, are reported to alter
host susceptibility and may con-
tribute to persistence of hantavi-
ruses in rodents. Humans and
reservoir hosts differ in infection
outcomes and in immune respons-
es to hantavirus infection; thus,
understanding the mechanisms
mediating viral persistence and
the absence of disease in rodents
may provide insight into the pre-
vention and treatment of disease in
humans. Consideration of the co-
evolutionary mechanisms mediat-
ing hantaviral persistence and ro-
dent host survival is providing
insight into the mechanisms by
which zoonotic viruses have re-
mained in the environment for
millions of years and continue to
be transmitted to humans.
Hantaviruses are negative sense, envel-
oped RNA viruses (family: Bunyaviridae)
that are comprised of three RNA
segments, designated small (S), medium
(M), and large (L), which encode the viral
nucleocapsid (N), envelope glycoproteins
(GN and GC), and an RNA polymerase
(Pol), respectively. More than 50 hantavi-
ruses have been found worldwide [1].
Each hantavirus appears to have co-
evolved with a specific rodent or insecti-
vore host as similar phylogenetic trees are
produced from virus and host mitochon-
drial gene sequences [2]. Spillover to
humans causes hemorrhagic fever with
renal syndrome (HFRS) or hantavirus
cardiopulmonary syndrome (HCPS), de-
pending on the virus [3–5]. Although
symptoms vary, a common feature of both
HFRS and HCPS is increased permeabil-
ity of the vasculature and mononuclear
infiltration [4]. Pathogenesis of HRFS and
HCPS in humans is hypothesized to be
mediated by excessive proinflammatory
and CD8+ T cell responses (Table 1).
In contrast to humans, hantaviruses
persistently infect their reservoir hosts,
presumably causing lifelong infections
[6]. Hantaviruses are shed in saliva, urine,
and feces, and transmission among rodents
or from rodents to humans occurs by
inhalation of aerosolized virus in excre-
ment or by transmission of virus in saliva
during wounding [7,8]. Although widely
disseminated throughout the rodent host,
high amounts of hantaviral RNA and
antigen are consistently identified in the
lungs of their rodent hosts, suggesting that
the lungs may be an important site for
maintenance of hantaviruses during per-
sistent infection [9–18]. Hantavirus infec-
tion in rodents is characterized by an acute
phase of peak viremia, viral shedding, and
virus replication in target tissues, followed
by a persistent phase of reduced, cyclical
virus replication despite the presence of
high antibody titers (Figure 1) [12–16,18–
20]. The onset of persistent infection
varies across hantavirus–rodent systems,
but generally the acute phase occurs
during the first 2–3 weeks of infection
and virus persistence is established there-
after (Figure 1).
Hantavirusinfectionalonedoesnotcause
disease, as reservoir hosts and non-natural
hosts (e.g., hamsters infected with Sin
Nombre virus [SNV] or Choclo virus)
may support replicating virus in the absence
of overt disease [12,14,16,18,21,22]. Our
primary hypothesis is that certain immune
responses that are mounted in humans
during hantavirus infection are suppressed
in rodent reservoirs to establish and main-
tain viral persistence, while preventing
disease (Table 2). During the coevolution
of hantaviruses with their reservoir hosts,
the viruses may have evolved mechanisms
to enhance persistence, including immune
evasion, direct suppression or alteration of
host antiviral, proinflammatory, and cellu-
larimmuneresponses,and inductionof host
regulatory responses. Alternatively, hosts
may have evolved adaptations, including
immunological responsiveness to steroid
hormones and pre-existing host genetic
factors, to regulate the detrimental effects
of infection, which also may affect persis-
tence of hantaviruses.
Virus-Mediated Responses to
Hantaviruses
Immune evasion. Mechanisms of
immune evasion, including viral mutation
and segment reassortment, may contribute
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Categorical
Response Immune Marker
Effect of
Infection Virus Species
a
In Vitro/In
Vivo
Tissue or Cell Type
b, Phase of
Infection
c References
Innate RIG-I Elevated SNV In vitro HUVEC, #24 h p.i. [79]
Reduced NY-1V In vitro HUVEC, #24 h p.i. [37]
TLR3 Elevated SNV In vitro HUVEC, #24 h p.i. [79]
IFN-b Elevated PUUV, PHV, ANDV In vitro HSVEC, HMVEC-L, #24 h p.i. [36,80]
Reduced TULV, PUUV NSs In vitro COS-7 and MRC5 cells, #24 h
p.i.
[32,33]
IFN-a Elevated PUUV, HTNV In vitro MF, DCs, 4 days p.i. [30]
No change HTNV In vivo Blood, acute [81]
IRF-3, IRF-7 Elevated SNV, HTNV, PHV, ANDV In vitro HMVEC-L, #24 h p.i. [33,38]
MxA Elevated HTNV, NY-1V, PHV, PUUV, ANDV,
SNV, TULV
In vitro MF,HUVEC,HMVEC-L, 6 h–4
days p.i.
[36,39–41,79]
MHC I and II Elevated HTNV In vitro DCs, 4 days p.i. [30]
CD11b Elevated PUUV In vivo Blood, acute [82]
CD40, CD80, CD86 Elevated HTNV In vitro DCs, 4 days p.i. [30,83]
NK cells Elevated PUUV In vivo BAL, acute [84]
Proinflammatory/
Adhesion
IL-1b Elevated SNV, HTNV In vivo Blood, lungs, acute [85,86]
IL-6 Elevated SNV, PUUV In vivo Blood, lungs, acute [85,87,88]
TNF-a Elevated PUUV, SNV, HTNV In vivo Blood, lungs, kidney, acute [85,86,88,89]
Elevated HTNV In vitro DCs, 4 days p.i. [30]
CCL5 Elevated SNV, HTNV In vitro HMVEC-L, HUVEC, 12 h–4 days
p.i.
[38,39,90]
CXCL8 Elevated PUUV In vivo Blood, acute [82]
Elevated PUUV In vivo Men, blood, acute [62]
Elevated TULV, PHV, HTNV In vitro HUVEC, MF, 2–4 days p.i. [39,91]
CXCL10 Elevated SNV, HTNV, PHV In vitro HMVEC-L,HUVEC, 3–4 days p.i. [38,39]
Elevated PUUV In vivo Men, blood, acute [62]
IL-2 Elevated SNV, HTNV, PUUV In vivo Blood, lungs, acute [82,86]
Nitric oxide Elevated PUUV In vivo Blood, acute [92]
GM-CSF Elevated PUUV In vivo Women, blood, acute [62]
ICAM, VCAM Elevated PUUV In vivo Kidney, acute [87]
Elevated HTNV, PHV In vitro HUVEC, 3–4 days p.i. [30,39]
E-selectin Elevated PUUV In vivo Blood, acute [82]
CD8+ and CD4+ T
cells
IFN-c Elevated HTNV, SNV In vivo Blood, CD4+,CD8+, lungs, acute [81,86]
CD8+ Elevated DOBV, PUUV, HTNV In vivo Blood, BAL, acute [52,84,93]
Virus-specific IFN-
c+CD8+
Elevated PUUV, SNV In vivo PBMC, acute [45,94]
Perforin, Granzyme B Elevated PUUV In vivo Blood, acute [95]
CD4+CD25+
‘‘activated’’
Elevated DOBV, PUUV In vivo PBMC, acute [89,93]
IL-4 Elevated SNV In vivo Lungs, acute [86]
Regulatory ‘‘suppressor T cells’’
d Reduced HTNV In vivo Blood, acute [52]
IL-10 Elevated PUUV In vivo Blood, acute [86]
TGF-b Elevated PUUV In vivo Kidney, acute [89]
Humoral IgM, IgG, IgA, IgE Elevated All hantaviruses In vivo Blood [4]
aSNV, Sin Nombre virus; NY-1V, New York-1 virus; PUUV, Puumala virus; PHV, Prospect Hill virus; ANDV, Andes virus; TULV, Tula virus; HTNV, Hantaan virus; DOBV,
Dobrava virus.
bHUVEC, human umbilical vascular endothelial cells; HSVEC, human saphenous vein endothelial cells; HMVEC-L, human lung microvascular endothelial cells; COS-7,
African green monkey kidney fibroblasts transformed with Simian virus 40; MRC5, human fetal lung fibroblasts; MF, macrophages; DCs, dendritic cells; BAL,
bronchoalveolar lavage, PBMC, human peripheral blood mononuclear cells.
cAcute infection is during symptomatic disease in patients.
dSuppressor T cells likely represent cells currently referred to as regulatory T cells.
doi:10.1371/journal.ppat.1000172.t001
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Categorical Response Immune Marker
Effect of
Infection
Virus
Species
a Host, Tissue or Cell Type
b Phase of Infection
c References
Innate TLR7 Reduced SEOV Male Norway rats, lungs Acute, Persistent [19]
Elevated SEOV Female Norway rats, lungs Acute, Persistent [19]
RIG-I Elevated SEOV Female Norway rats, lungs Acute, Persistent [19]
Elevated SEOV Newborn rats, thalamus Acute [96]
TLR3 Elevated SEOV Male Norway rats, lungs Acute, Persistent [19]
IFN-b Reduced SEOV Male Norway rats, lungs Acute, Persistent [19,61]
Elevated SEOV Female Norway rat lungs Acute [19,61]
Mx2 Reduced SEOV Male Norway rats, lungs Acute, Persistent [19,60]
Elevated SEOV Female Norway rats, lungs Acute, Persistent [19,60]
Elevated HTNV, SEOV Mice
d, fibroblasts transfected with Mx2 3–4 days p.i. [97]
JAK2 Elevated SEOV Female Norway rats, lungs Acute [60]
MHC II Elevated PUUV Bank voles Genetic susceptibility [74]
Proinflammatory/
Adhesion
IL-1b Reduced SEOV Male Norway rats, lungs Persistent [29]
IL-6 Reduced SEOV Male and female Norway rats, lungs Acute, Persistent [29,61]
Elevated SEOV Male rats, spleen Acute [29]
TNF-a Reduced HTNV Newborn mice
d, CD8+, spleen Acute [49,50]
Reduced SEOV Male Norway rats, lungs Acute, Persistent [29,42,61]
Elevated SEOV Female Norway rats, lungs Persistent [61]
CX3CL1, CXCL10 Reduced SEOV Male Norway rats, lungs Acute, Persistent [29]
Elevated SEOV Male Norway rats, spleen Acute [29]
CCL2, CCL5 Elevated SEOV Male Norway rats, spleen Acute [29]
NOS2 Reduced SEOV Male Norway rats, lungs Acute, Persistent [29,61]
Elevated SEOV Male Norway rats, spleen Acute [29]
Elevated HTNV Mouse MF
d, in vitro 6 h p.i. [98]
VCAM, VEGF Elevated SEOV Male Norway rats, spleen Acute [29]
CD8+ and CD4+ T cells CD8+ Reduced HTNV Newborn mice
d, spleen Persistent [50]
Elevated HTNV SCID mice
d, CD8+ transferred, spleen Persistence [49]
Elevated SEOV Female Norway rats, lungs Persistent [61]
IFN-c Elevated SEOV Female Norway rats, lungs Persistent [61]
Elevated SEOV Male Norway rats, spleen Acute [29]
Elevated SEOV Male and female Norway rats, splenocytes Acute [20]
Elevated SNV Deer mice, CD4+ T cells Acute [48]
Elevated HTNV Newborn mice
d, CD8+ T cells, spleen Acute [50]
Reduced HTNV Newborn mice
d, CD8+ T cells, spleen Persistent [99]
IFN-cR Elevated SEOV Female Norway rats, lungs Acute, Persistent [60]
Reduced SEOV Male Norway rats, lungs Persistent [60]
T cells Elevated SEOV Nude rats Persistence [47]
Elevated HTNV Nude mice
d Persistence [100]
IL-4 Reduced SEOV Male Norway rats, lungs Acute, Persistent [61]
Elevated SNV Deer mice, CD4+ T cells Acute [48]
Elevated SEOV Male and female Norway rats, splenocytes Acute [20]
Regulatory Regulatory T cells Elevated SEOV Male Norway rats, lungs Persistent [42,61]
FoxP3 Elevated SEOV Male Norway rats, lungs Persistent [29,42,61]
TGF-b Elevated SEOV Male Norway rats, lungs Persistent [29]
SNV Deer mice, CD4+ T cells Persistent [48]
IL-10 Reduced SEOV Male Norway rats, lungs and spleen Acute, Persistent [29]
Elevated SNV Deer mice, CD4+ T cells Acute [48]
Humoral IgG Elevated SNV Deer mice Persistent [12,57]
Elevated SEOV Norway rats Persistent [16,17]
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virus (SEOV) L segment deletions and S
segment insertions in regions necessary for
initiation of transcription are observed in
vitro [6]; whether mutated RNAs can self-
repair and whether this occurs in vivo
remains to be determined. Quasispecies
have been identified in vivo in deer mice
(Peromyscus maniculatus) and European
common voles (Microtus arvalis)i n f e c t e d
with SNV and Puumala virus (PUUV),
respectively, with nucleotide and amino
acid mutations identified in immun-
odominant regions of the GN protein
[23,24]. Segment reassortment of
hantaviruses has been identified in Vero
E6 cells that are co-infected with related
strains of SNV and in vivo in deer mice
infectedwithSNV[25,26].Recentdataalso
suggest that a newly discovered hantavirus
inParaguaymaybea reassortmentbetween
Laguna Negra or Rio Mamore ´v i r u s e sw i t h
Pergamino or Maciel viruses [27].
Quasispecies and reassortants likely
contribute to the evolution of new species
of hantaviruses, but also may be involved in
immune evasion.
Direct alteration of host cellular
responses. Hantaviruses can infect
macrophages and endothelial cells in
rodents and humans [13,14,16,28]. These
cell types have been identified primarily by
morphological analyses or by non-specific
cell separation. Recently, SEOV N protein
was definitively identified in macrophages
and endothelial cellsin lung tissue of infected
rats using cell-specific antibodies [29].
Hantaan virus (HTNV) infects human
dendritic cells (DCs) in vitro and induces
DC activation and maturation [30].
Whether rodent DCs are infected by hanta-
viruses and whether rodent macrophage
and DC activity is suppressed by hantavirus
infection to cause persistence remains
unknown. Several viruses in the
Bunyaviridae family encode a non-
structural protein (NSs) that suppresses
antiviral immune responses in infected cells
[31]. The S segment of PUUV and Tula
virus (TULV) has an open reading frame
(ORF) for NSs, a protein that reduces the
expression of IFN-b in human lung
fibroblasts and contributes to virus survival
in vitro [32,33]. Immunoreceptor tyrosine-
based activation motifs (ITAMs) that bind
k i n a s e st or e g u l a t ei m m u n ea n de n d o t h e l i a l
cell function have been identified in the GN
protein of hantaviruses [34,35].
Additionally, the cytoplasmic tails of
HCPS-causing hantavirus G proteins
inhibit the expression of type I IFN
responses in human umbilical vein
endothelial cells (HUVECs) and human
lung microvascular endothelial cells
(HMVEC-Ls) in vitro [36,37]. Whether
hantavirus proteins and RNA have
immunomodulatory activity in rodent
reservoirs remains unknown.
Host-Mediated Responses to
Hantaviruses
Innate antiviral and proinflam-
matory responses. Infection of
HMVEC-Ls and HUVECs indicate that at
least some of the hantaviruses that cause
diseaseinhumans(e.g.,HTNV,Andesvirus
[ANDV],SNV,NewYork-1virus[NY-1V],
PUUV, and SEOV) delay induction of
factors in the type I IFN pathway (e.g.,
production of IFN-a, IFN-b, and MxA) as
compared with hantaviruses that cause no
known disease in humans (e.g., TULV and
Prospect Hill virus [PHV]) [36,38–41].
Delayed production of antiviral responses
in humans may contribute to more efficient
replication of pathogenic hantaviruses than
non-pathogenic hantaviruses. Despite
delayed induction of type I IFNs, human
cells mount innate antiviral responses that
also may contribute to viral clearance.
In the lungs of rats with high amounts of
virus (i.e., male rats), the expression of
pattern recognition receptors (i.e., Rig-I and
Tlr7) is reduced or remains unchanged
throughoutSEOVinfection,suggestingthat
inhibition of viral recognition may contrib-
ute to the establishment of persistent
Categorical Response Immune Marker
Effect of
Infection
Virus
Species
a Host, Tissue or Cell Type
b Phase of Infection
c References
Elevated HTNV Field mice Persistent [15]
Elevated PUUV Bank voles Persistent [14]
Elevated BCCV Cotton rats Persistent [18,58]
aSEOV, Seoul virus; HTNV, Hantaan virus, PUUV, Puumala virus; SNV, Sin Nombre virus; PUUV, Puumala virus; BCCV, Black Creek Canal virus.
bMF, macrophages.
cAcute infection is ,30 days p.i. and persistent infection is $30 days p.i.
dMus musculus, non-natural reservoir host for hantaviruses.
doi:10.1371/journal.ppat.1000172.t002
Figure 1. Kinetics of Hantavirus Infection in Rodents. Adapted from Lee et al. [15] and
others [12–14,16,18,20], the kinetics of relative hantaviral load in blood (red), saliva (green), and
lung tissue (blue) and antibody responses (black) during the acute and persistent phases of
infection are represented. The amount of genomic viral RNA, infectious virus titer, and/or relative
amount of viral antigen have been incorporated as relative hantaviral load. The antibody
response is integrated as the relative amount of anti-hantavirus IgG and/or neutralizing antibody
titers.
doi:10.1371/journal.ppat.1000172.g001
Table 2. Continued.
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IFN-b,M x 2 ,a n dI F N - c) and proinflamma-
tory (e.g., IL-1b,T N F - a, and NOS2)
responses are reduced or unaltered during
infection in the lungs of male rats, which
also may contribute to hantavirus persis-
tence [19,29,42]. In contrast, in the spleen,
a peripheral immune organ that supports
low amounts of virus, the expression and
production of proinflammatory and antivi-
ral factors are elevated during acute SEOV
infection and subsequently return to base-
line [20,29]. Thus, rats infected with SEOV
do not appear to be globally immunosup-
pressed, but rather have a site-specific
reduction of proinflammatory responses.
There is no evidence that male rats that
are naturally infected with SEOV are more
likely to acquire additional pathogens,
further illustrating that infected rats are
notimmunocompromised[43].Conversely,
natural populations of deer mice that have
antibody against SNV elicit a lower re-
sponse to phytohemagglutinin (i.e., a mea-
sure of immunocompetence) than their
uninfected counterparts, suggesting that
SNV causes some degree of immunosup-
pression in deer mice [44]. Administration
of exogenous IL-1b, which elevates circu-
lating IL-1b and Il6 and Tnfa expression in
the lungs within physiological ranges, does
not affect SEOV persistence in male rats
nor does it cause observable disease [29].
Thus, extremely high proinflammatory
responses observed during acute infection
in humans may be necessary for viral
clearance at the expense of causing poten-
tially fatal proinflammatory-mediated dis-
ease.
CD4+ and CD8+ T cell res-
ponses. Cellular immune responses, in
particular CD8+ T cells, contribute to
clearance of hantaviruses in humans at the
expense of causing disease [45,46].
Following inoculation with SEOV, nude
(i.e., T cell deficient) rats have more virus in
target tissues and shed more infectious virus
than do their immunocompetent coun-
terparts and die 10 weeks after inoculation,
indicating that T cells contribute to the
control of virus replication and survival in a
reservoir host [47]. During the acute phase
of SNV infection, deer mice have observable
Th1 and Th2 responses (i.e., elevated
expression of Ifnc, Gata3 [i.e., the hallmark
Th2 transcription factor], Il4,a n dIl5)i n
cultured CD4+ Tc e l l s ,w h i c ha r en o t
evident in CD4+ T cells isolated from
persistently infected deer mice [48]. In
severe-combined immunodeficient (SCID)
mice(Musmusculus),thetransferoffunctional
CD8+ T cells is necessary for clearance of
HTNV [49]. Persistence of HTNV in
newborn BALB/c mice is correlated with a
decrease in HTNV-specific CD8+ Tc e l l
numbers and activity, as measured by IFN-c
production, further suggesting a role of
functional CD8+ T cell responses in viral
clearance [49,50]. Not only are laboratory
mice non-natural hosts, but SCID and
newborn mice do not have fully functional
immune systems, so these models do not
accurately represent viral persistence in
immunocompetent rodent reservoir
populations. The effect of infection on
hantavirus-specific CD8+ T cells in adult
rodent reservoir hosts requires examination.
Regulatory T cell responses. Regul-
atory T cell responses suppress proinflam-
matory and effector T cell responses locally
a tt h es i t eo fi n f e c t i o nt oa l l o wp a t h o g e n
persistence, as well as to mitigate
proinflammatory-mediated pathogenesis
[51]. Recent studies have demonstrated
that regulatory T cells contribute to
SEOV and SNV persistence in rats and
deer mice, respectively [42,48]. Expression
of Foxp3 mRNA and proportions of
CD4+CD25+FoxP3+ regulatory T cells
are elevated locally at a site of elevated
SEOV replication (i.e., in the lungs) in male
rats during persistent SEOV infection
[29,42]. Functional inactivation of
regulatory T cells reduces the amount of
SEOV RNA present in the lungs and the
proportion of animals shedding viral RNA
in saliva [42]. In the lungs, the expression
and production of TGF-b is elevated and
TNF-a is suppressed during persistent
infection; both cytokine expression
patterns are dependent on the presence of
functional regulatory T cells [42]. Similarly,
CD4+ T cells isolated from deer mice
during the persistent phase of SNV
infection have higher expression of Tgfb
than do CD4+ T cells isolated from deer
mice during the acute phase of infection
[48].TheproductionofIL-10isconsistently
reduced throughout SEOV and during the
persistent phase of SNV infection in rats
and deer mice, respectively, revealing that
IL-10 does not contribute to regulatory T
cell–mediated hantaviral persistence
[29,42,48]. Because responses to
hantavirus infection in humans involve
overproduction of proinflammatory
cytokines, it is consistent that ‘‘regulatory
T cell activity’’ (i.e., T cells which reduce
ConA-induced proliferation of PBMCs) is
suppressed during symptomatic HTNV
infection in humans [52]; whether
suppressed regulatory T cell responses
contribute to disease in humans requires
consideration.
Antibody responses. Hantaviruses
persist in their rodent hosts despite the
presence of neutralizing antibody. Antibody
against hantaviruses is usually detectable
after the first 2 weeks of infection, rapidly
increases for the next 4–6 weeks, and
declines, but remains detectable
presumably for the lifetime of the rodent
(Figure 1) [9,13–16,18,29]. Hantavirus-
specific antibody responses, although not
capable of eliminating virus, can serve a
protective role against infection. Maternal
antibody protects offspring of hantavirus-
infected dams during the first 2 months of
life (i.e., when the immune system is not
fully developed) in various rodent reservoirs
[53–55]. Not only are young rodents
protected from hantavirus infection, but
young male and female bank voles with
maternal antibody against PUUV also
mature earlier, suggesting that
reproductive success may be increased in
bank voles with, as compared to bank voles
without, maternal antibody [54]. How
hantaviruses evade antibody responses in
their rodent hosts remains to be answered.
Sex differences and sex
steroids. In natural populations of
rodent reservoirs, males are more
frequently infected with hantaviruses and
are more likely to engage in aggressive
encounters than are females, which may
result in elevated exposure and transmission
of hantaviruses among males [10,56–59].In
laboratory settings, when given the same
challenge, male rats have more SEOV
RNA and antigen in target organs and
saliva than do females [19,20]. Removal of
the testes in males (i.e., reduction of
androgens to non-detectable levels)
reduces, whereas removal of the ovaries in
females (i.e., reduction of estrogens and
progesterone to non-detectable levels)
increases SEOV RNA loads as compared
with their intact counterparts [19].
Consistent with sex differences in SEOV
load, the expression of innate antiviral (e.g.,
Tlr7, Myd88, Rig-I, Visa, Ifnb,a n dMx2)a n d
proinflammatory (e.g., Tnfa and Ccl5)
factors is higher in the lungs of female
than male rats [11,19,60,61]. Similarly,
immunocompetence, as measured by
swelling in response to PHA, is higher in
female than in male deer mice during SNV
infection [44]. Conversely, the expression
and production of regulatory factors,
including Foxp3 and TGF-b, is elevated in
the lungs of males as compared with those
of females [61]. These sexually dimorphic
immune responses may be dependent on
estradiol in females and testosterone in
males, as gonadectomy reverses these
differences [19,60]. It is plausible that
reduced innate and proinflammatory
defenses and elevated regulatory responses
combined with an increased propensity to
engage in aggression may contribute to
increased maintenance and transmission of
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among femalerodents. Whether thereexists
a sexual dimorphism in the risk of zoonotic
transmission of hantaviruses should
continue to be considered.
Sex differences in response to hantavi-
rus infection in humans are beginning to
receive attention. During acute PUUV
infection in humans, circulating concen-
trations of CXCL8 and CXCL10 are
higher, whereas concentrations of IL-9
and GM-CSF are lower in men than in
women [62]. Although a similar propor-
tion of men and women have antibodies
against PUUV [63], men are more likely
to develop symptoms of disease (i.e., be
hospitalized) during PUUV infection than
are women [62,64]. Whether sexually
dimorphic immune responses during han-
tavirus infection cause differences in the
severity of disease between men and
women requires further investigation.
Glucocorticoids. Glucocorticoids are
potent immunosuppressive steroid
hormones that can suppress
proinflammatory and cellular responses
and have been administered to patients
with HFRS or HCPS to reduce
immunopathology [65,66]. Infection of
humans with either HTNV or PUUV
causes pituitary and adrenal necrosis,
which may contribute to the reduced
concentrations of cortisol and elevated
proinflammatory responses in patients
during the acute phase of infection
[67,68]. In rats, circulating concentrations
of corticosterone are reduced during SEOV
infection in males, but not in females [61].
Males with reduced concentrations of
glucocorticoids have more SEOV RNA in
the lungs than do males with elevated
concentrations [61]. No such relationship
between glucocorticoid concentration and
SEOV load is observed in females [61].
Low concentrations of corticosterone
correlate with elevated regulatory
responses (i.e., expression of Foxp3 and
production of TGF-b) and expression of
the glycogenase, matrix metalloprotease
(Mmp)-9, in the lungs of male, but not
female, rats during SEOV infection [61].
Increased production of MMP-9 may
disrupt the basement membrane and
extracellular matrices in tissues to increase
virus dissemination in male rats [69].
Whether hantaviruses alter glucocorticoids
in other reservoir hosts requires further
investigation. Based on our data,
administration of corticosteroids to
patients with HFRS or HCPS would not
be expected to cause chronic hantavirus
infection and may even reduce viral
dissemination in tissues.
Genetic factors. Host genetic factors
may contribute to susceptibility to and
outcome of hantavirus infection in both
humans and rodent hosts. Patients with
TNF polymorphisms associated with
elevated or reduced TNF-a transcription
are predisposed to exhibit more severe
disease during PUUV infection [70,71].
Possession of certain HLA haplotypes (i.e.,
HLA B8-DR3, C4A*Q0, and
DRB1*0301) is a risk factor for severe
disease during PUUV infection in
humans, illustrating that antigen
presentation and T cell responses likely
contribute to the severity of disease
[72,73]. Several MHC alleles may alter
susceptibility in rodent reservoirs,
specifically Cgl-DQA-09, which is
positively, and Cgl-DQA-05 and Cgl-
DQA-12, which are negatively, associated
with the likelihood of bank voles being
infected with PUUV [74]. Because
uninfected bank voles may never have
been exposed to PUUV, whether these
specific MHC alleles alter susceptibility
following a known exposure to PUUV
remains to be determined.
Conclusions
Hantaviruses and their rodent reservoirs
represent highly coevolved systems in
which virulence and host responses have
been adapted to ensure survival of both
the virus and the host. The current
literature suggests that hantavirus persis-
tence is mediated by both the virus and the
host. Although several potential mecha-
nisms mediating the persistence of hanta-
viruses in their rodent hosts have been
discovered in recent years, there are a
number of intriguing questions that re-
main to be addressed:
N Do hantaviral NSs inhibit type I IFN
responses in rodents and therefore
contribute to viral persistence?
N Is DC and macrophage activity (e.g.,
antigen presentation, cytokine produc-
tion, and T cell activation) suppressed
by hantavirus infection in rodent
reservoirs?
N Does suppression of excessive proin-
flammatory cytokine responses (e.g.,
TNF-a) prevent disease in rodents at
the cost of causing viral persistence?
N Is the activity of hantavirus-specific
CD8+ T cells suppressed during infec-
tion to mediate viral persistence in
rodents?
N How is regulatory T cell activity
induced by hantaviruses in reservoir
hosts?
N What is the mechanism of regulatory
T cell–mediated hantaviral persistence
(e.g., suppression of proinflammatory
and/or CD8+ T cell activity)?
N Do host genetic factors, in addition to
MHC alleles, contribute to the suscep-
tibility of rodents to hantaviruses?
N What is the role of non-immune
mediators, including MMP-9 [61]
and receptor use for cellular entry
[75,76], in hantaviral dissemination
and persistence in rodents?
We propose that comparing immune
responses in rodents to those in humans
may provide insight into ways to prevent
pathology in humans. Although advances
are being made in the development of a
hantavirus vaccine, there currently is no
FDA-approved vaccine or drug for pre-
vention or treatment of hantaviral disease
[77,78]. Elevated regulatory T cell re-
sponses in rodents contribute to hantavirus
persistence, possibly by suppressing proin-
flammatory responses (i.e., production of
TNF-a) [42,48]. Regulatory T cell re-
sponses during hantavirus infection have
not been well characterized in humans,
but may be downregulated [52] and
contribute to symptoms of HFRS and
HCPS. Targeted manipulation of regula-
tory T cell responses by adoptive transfer
of regulatory T cells, administration of
anti-TNFa therapy, or treatment with
glucocorticoids may control the ‘‘cytokine
storm’’ that is initiated when hantaviruses
infect humans and cause severe immuno-
pathology. Understanding the mecha-
nisms mediating viral persistence in the
absence of disease in reservoir hosts may
contribute to advances in the treatment of
HFRS and HCPS in humans.
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